Improvement of Liver Transplantation Outcome by Heme Oxygenase-1-Transduced Bone Marrow Mesenchymal Stem Cells in Rats

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Wu, Bin ^a   Song, Hong Li ^a,b   Yang, Yang ^c   Yin, Ming Li ^c   Zhang, Bo Ya ^c   Cao, Yi ^c   Dong, Chong ^a   Shen, Zhong Yang ^a  

^a TIANJIN FIRST CENTRAL HOSPITAL   (China)

^b Tianjin Key Laboratory of Organ Transplantation   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ADULT; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; GRAFT SURVIVAL; IMMUNOMODULATION; IN VITRO STUDY; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 84956633007     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/9235073     Document Type: Article

References (32)

1. M. Desai and J. Neuberger, "Chronic liver allograft dysfunction," Transplantation Proceedings, vol. 41, no. 2, pp. 773-776, 2009.
2. M. J. Weiss, C. Y. Ng, and J. C. Madsen, "Tolerance, xenotransplantation: future therapies," Surgical Clinics of North America, vol. 86, no. 5, pp. 1277-1296, 2006.
3. A. Bertolo, T. Thiede, N. Aebli, M. Baur, S. J. Ferguson, and J. V. Stoyanov, "Humanmesenchymal stem cell co-culture modulates theimmunological properties of human intervertebral disc tissue fragments in vitro," European Spine Journal, vol. 20, no. 4, pp. 592-603, 2011.
4. M. Barone,M. P. Scavo,E. Maiorano, A. Di Leo, and A. Francavilla, "Bonemarrow-derived stemcells and hepatocarcinogenesis in hepatitis B virus transgenic mice," Digestive and LiverDisease, vol. 46, no. 3, pp. 243-250, 2014.
5. M. Muraca, "Evolving concepts in cell therapy of liver disease and current clinical perspectives," Digestive and Liver Disease, vol. 43, no. 3, pp. 180-187, 2011.
6. Y.-R. Kuo, C.-C. Chen, S. Goto, P.-Y. Lin, F.-C. Wei, and C.-L. Chen, "Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation," Clinical and Developmental Immunology, vol. 2012, Article ID 854846, 8 pages, 2012.
7. J. L. Reading, S. Sabbah, S. Busch, and T. I. M. Tree, "Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation," Current Opinion in Organ Transplantation, vol. 18, no. 1, pp. 59-64, 2013.
8. M. M. Duffy, J. Pindjakova, S. A. Hanley et al. , "Mesenchymal stem cell inhibition of T-helper 17 cell-differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor," European Journal of Immunology, vol. 41, no. 10, pp. 2840-2851, 2011.
9. H. Song, K. Kwon, S. Lim et al. , "Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions,"Molecules and Cells, vol. 19, no. 3, pp. 402-407, 2005.
10. N. G. Abraham and A. Kappas, "Pharmacological and clinical aspects of heme oxygenase," Pharmacological Reviews, vol. 60, no. 1, pp. 79-127, 2008.
11. S. Brouard, L. E. Otterbein, J. Anrather et al. , "Carbonmonoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis," Journal of Experimental Medicine, vol. 192, no. 7, pp. 1015-1025, 2000.
12. K. Sodhi, N. Puri, G. Favero et al. , "Fructose mediated nonalcoholic fatty liver is attenuated by HO-1-SIRT1 module in murine hepatocytes and mice fed a high fructose diet," PLoS ONE, vol. 10, no. 6, Article IDe0128648, 2015.
13. T. Tsubokawa, K. Yagi, C. Nakanishi et al. , "Impact of antiapoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 5, pp. H1320-H1329, 2010.
14. A. Zarjou, J. Kim, A. M. Traylor et al. , "Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1," American Journal of Physiology-Renal Physiology, vol. 300, no. 1, pp. F254-F262, 2011.
15. J.-G. Li, Y.-X. Zhuan-sun, B. Wen et al. , "Human mesenchymal stem cells elevate CD4+CD25+CD127low/-regulatory T cells of asthmatic patients via heme oxygenase-1," Iranian Journal of Allergy, Asthma and Immunology, vol. 12, no. 3, pp. 228-235, 2013.
16. K. Yamashita, R. Ollinger, J. McDaid et al. , "Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs," The FASEB Journal, vol. 20, no. 6, pp. 776-778, 2006.
17. C. P. Hodgkinson, J. A. Gomez, M. Mirotsou, and V. J. Dzau, "Genetic engineering of mesenchymal stem cells and its application in human disease therapy," Human GeneTherapy, vol. 21, no. 11, pp. 1513-1526, 2010.
18. L. Vanella, D. H. Kim, D. Asprinio et al. , "HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage," Bone, vol. 46, no. 1, pp. 236-243, 2010.
19. D. Chabannes, M. Hill, E. Merieau et al. , "A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells," Blood, vol. 110, no. 10, pp. 3691-3694, 2007.
20. N.-N. Fu, H.-L. Song, B.-J. Wu, and T. Liu, "Effects of HO-1 modified rat bone marrow mesenchymal stemcells on lymphocytes in vitro," Chinese Journal of Microbiology and Immunology, vol. 33, no. 11, pp. 801-806, 2013.
21. M. F. Pittenger, A. M. Mackay, S. C. Beck et al. , "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999.
22. N. Kamada and R. Y. Calne, "Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage," Transplantation, vol. 28, no. 1, pp. 47-50, 1979.
23. A. J. Demetris, K. P. Batts, A. P. Dhillon et al. , "Banff schema for grading liver allograft rejection: an international consensus document," Hepatology, vol. 25, no. 3, pp. 658-663, 1997.
24. S. A. Lodhi, K. E. Lamb, and H. U. Meier-Kriesche, "Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success," American Journal of Transplantation, vol. 11, no. 6, pp. 1226-1235, 2011.
25. S. Glennie, I. Soeiro, P. J. Dyson, E. W.-F. Lam, and F. Dazzi, "Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells," Blood, vol. 105, no. 7, pp. 2821-2827, 2005.
26. K. A. Newell, "Clinical transplantation tolerance," Seminars in Immunopathology, vol. 33, no. 2, pp. 91-104, 2011.
27. I. N. Crispe, "HepaticTcells and liver tolerance," Nature Reviews Immunology, vol. 3, no. 1, pp. 51-62, 2003.
28. O. Alpdogan and M. R. M. van den Brink, "Immune tolerance and transplantation," Seminars in Oncology, vol. 39, no. 6, pp. 629-642, 2012.
29. J.-F. Feng, F. Chen,H. Liu, and J. Liu, "Induction of immune tolerance by pre-infusion of apoptotic lymphocytes derived from peripheral blood of donor rats before liver transplantation," Minerva Chirurgica, vol. 68, no. 2, pp. 183-189, 2013.
30. D. Hanidziar and M. Koulmanda, "Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance," Current Opinion in Organ Transplantation, vol. 15, no. 4, pp. 411-415, 2010.
31. D. Budak, V. T. Yilmaz, H. Akbas et al. , "Association between graft function and serum TNF-α TNFR1 and TNFR2 levels in patients with kidney transplantation," Renal Failure, vol. 24, pp. 1-6, 2015.
32. E. M. Shevach, "Mechanisms of Foxp3+ T regulatory cell mediated suppression," Immunity, vol. 30, no. 5, pp. 636-645, 2009.